Actively Recruiting
Optimizing an Intervention to Increase Oral Medication Adherence for Patients with Metastatic Breast Cancer
Led by European Institute of Oncology · Updated on 2024-12-20
104
Participants Needed
1
Research Sites
61 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are working to improve a program aimed at helping patients with metastatic breast cancer take their oral anticancer medicines as prescribed. The study focuses on finding the best combination of three support methods: educational information, personalized reminders, and feedback from doctors. This research addresses the common problem that many patients have trouble sticking to their medication schedules, especially with oral treatments preferred for their convenience. Participants may receive different types of support during the study. Some will get standard care without extra help, while others will access educational materials online through a decision support system. Personalized reminders will be sent through a messaging app called WhatsApp, and feedback messages from physicians will be provided after reviewing patients' medication diaries. These interventions will help identify which combination best improves medication adherence. During the study, participants will use their smartphones to receive reminders and access educational content. Researchers will monitor how well patients follow their medication plans over seven months, tracking adherence to oral medication. The study also includes scheduled visits and assessments to ensure participants can comply with the procedures. Language understanding, diary reviews, and communication through WhatsApp will be part of the process to support and measure participant involvement.
CONDITIONS
Official Title
Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a diagnosis of metastatic BC
- Patients with a prescription for any oral anticancer agent (oral chemotherapy, endocrine therapy, or Cyclin-Dependent Kinase 4/6 Inhibitors)
- Age over 18 years old
- Personal smartphone with internet access
- Willingness and ability to comply with scheduled visits and trial procedures
- Understanding and speaking Italian
- Written informed consent
You will not qualify if you...
- Psychiatric disorders or conditions impairing the ability to give informed consent
- Comorbidities that may affect compliance with study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
European Institute of Oncology
Milan, Italy, 20141
Actively Recruiting
Research Team
G
Gabriella Pravettoni, MD
M
Mara Negri
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
8
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here